Form:	Chile-US Outcomes Baseline v1.11

CDE ID	CDE Description
* 421	EDRN Participant ID (Go To: 2176)
* 2176	Visit code (Go To: 423)
	Permissible Values (value): BLN1 (1)
	BLN2 (2)
	BLN3 (3)
	BLN4 (4)
* 423	EDRN Protocol ID (Go To: 422)
* 422	EDRN Site ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 4556)
* 4556	Date of contact (DD/MM/YYYY): (Go To: 4004)
* 4004	Were any of the following abnormalities suspicious for mesothelioma detected? (Check all that apply) (Go To: 3028)
	Permissible Values (value): None (0)
	Pleural effusion (1)
	Pleural ascites (2)
	Pulmonary nodules (3)
	Asymmetrical pleural thickening characterized by the presence of pleural nodularity (4)
	Refused (88)
	Unknown (99)
* 3028	Diagnosed with study-related cancer?: (Go To: 4005)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 4555)
	Refused (88)
	Unknown (99)
4555	Date of diagnosis (DD/MM/YYYY): (Go To: 3107)
* 3107	Mesothelioma T-stage (Go To: 3105)
	Permissible Values (value): TX (1)
	T0 (2)
	T1 (11)
	T1a (12)
	T1b (13)
	T2 (20)
	T3 (30)
	T4 (40)
* 3105	Mesothelioma N-stage (Go To: 3104)
	Permissible Values (value): NX (1)
	N0 (2)
	N1 (30)
	N2 (40)
	N3 (50)
* 3104	Mesothelioma M-stage (Go To: 3106)
	Permissible Values (value): MX (1)
	M0 (2)
	M1 (3)
* 3106	AJCC mesothelioma stage grouping: (Go To: 4005)
	Permissible Values (value): Stage I (2)
	Stage IA (3)
	Stage IB (6)
	Stage II (20)
	Stage III (30)
	Stage IV (40)
* 4005	Is the participant able to undergo therapy for cancer? (Go To: 1097)
	Permissible Values (value): No (0) (Go To: End of Form)
	Yes (1)
	Refused (88) (Go To: End of Form)
	Unknown (99) (Go To: End of Form)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)